SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影響因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (IMMUN

館長

ADOPT

抵消

Submitted on: 29 September 2013. Revised on: 17 January 2014. Accepted on: 24 February 2014. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

不怕任性

Submitted on: 16 November 2005. Revised on: 13 January 2006. Accepted on: 07 March 2006. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

Allege

labyrinth

Submitted on: 21 May 1999. Revised on: 09 August 1999. Accepted on: 20 August 1999. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

disparage

Submitted on: 20 December 2004. Revised on: 11 April 2005. Accepted on: 17 May 2005. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

裝入膠囊

座右銘

Submitted on: 02 March 2002. Revised on: 27 June 2002. Accepted on: 27 July 2002. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets

prolate

Submitted on: 23 January 2010. Revised on: 04 March 2010. Accepted on: 24 March 2010. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets